Aerie Pharmaceuticals
AERI
#5969
Rank
โ‚น63.58 B
Marketcap
โ‚น1,287
Share price
0.00%
Change (1 day)
86.06%
Change (1 year)

Revenue for Aerie Pharmaceuticals (AERI)

Revenue in 2022 (TTM): โ‚น16.36 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น18.05 Billion. In 2021 the company made a revenue of โ‚น14.44 Billion an increase over the revenue in the year 2020 that were of โ‚น6.08 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aerie Pharmaceuticals from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น16.36 B13.28%
2021 โ‚น14.44 B137.65%
2020 โ‚น6.08 B22%
2019 โ‚น4.98 B194.76%
2018 โ‚น1.69 B
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น28.93 B 60.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.30 B-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.271 T 29,103.85%๐Ÿ‡บ๐Ÿ‡ธ USA